UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023676 |
|---|---|
| Receipt number | R000027268 |
| Scientific Title | Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2023/07/28 11:07:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/08/18 20:08:41 | ||
| 2 | Update | 2016/08/18 20:09:32 | Recruitment status |
|
| 3 | Update | 2016/09/15 15:26:23 | Narrative objectives1 |
|
| 4 | Update | 2017/02/17 09:09:16 | Primary outcomes Primary outcomes |
|
| 5 | Update | 2017/07/05 15:15:07 | Recruitment status |
|
| 6 | Update | 2017/08/21 15:22:11 | Primary outcomes |
|
| 7 | Update | 2018/01/04 10:42:16 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 8 | Update | 2019/09/20 13:33:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Homepage URL Organization Organization Address Address Tel |
|
| 9 | Update | 2019/09/20 13:34:38 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 10 | Update | 2020/10/10 12:22:11 | Key secondary outcomes Key secondary outcomes |
|
| 11 | Update | 2021/08/23 08:49:36 | Last follow-up date |
|
| 12 | Update | 2021/10/14 12:25:48 | Key secondary outcomes Key secondary outcomes |
|
| 13 | Update | 2023/07/28 11:07:01 | Target sample size |
